August 18th, 2010 by admin
Interleukin Genetics Inc. (OTC: ILIU) is no longer traded on the New York Stock Exchange. The company transferred its common stock to the OTCQB marketplace because it could no longer meet NYSE listing requirements, though the recent quarter’s results improved.
«« Read More
August 18th, 2010 by admin
ST. LOUIS, Miss., Aug. 17 (UPI) — U.S. scientists say they will undertake a project to sequence the genetic content of all the bacteria that live in the human body — about 900 types. Bacteria – United States – Human – Biology – Genetics
«« Read More
August 17th, 2010 by admin
The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene [...]
«« Read More
August 17th, 2010 by admin
Using a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardation. Instead of sequencing the entire human genome, the new approach sequences just the exome, the 1-2 percent of the human genome [...]
«« Read More
August 17th, 2010 by admin
NHGRI-supported researchers streamline DNA sequencing strategies to find rare disease genes quicklyUsing a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardation. Instead of sequencing the entire human genome, the new approach [...]
«« Read More
August 17th, 2010 by admin
A new study reports that the physical variance among dog breeds is determined by differences in only about seven genetic regions.
«« Read More
August 17th, 2010 by admin
How a Heart Healthy Diet Can Decrease the Risk of Cardiovascular Disease The human heart is the miraculous organ in our body that pumps blood to every single cell. About the size of your fist, it pumps blood into your lungs and through your arteries, veins and, capillaries. This complex muscle works efficiently when a [...]
«« Read More
August 17th, 2010 by admin
Researchers at Harvard Medical School, including genetics professor George Church, are changing the DNA or bacteria, with the goal of bringing the technology to the biotech, energy and chemicals industry, according to a Bloomberg report.
«« Read More
August 17th, 2010 by admin
Research conducted by Dr. Jay Kolls, Professor and Chair of Genetics at LSU Health Sciences Center New Orleans, and colleagues, has found that vitamin D may be an effective therapeutic agent to treat or prevent allergy to a common mold that can complicate asthma and frequently affects patients with cystic fibrosis.
«« Read More
August 17th, 2010 by admin
Research conducted by Dr. Jay Kolls, Professor and Chair of Genetics at LSU Health Sciences Center New Orleans, and colleagues, has found that vitamin D may be an effective therapeutic agent to treat or prevent allergy to a common mold that can complicate asthma and frequently affects patients with Cystic Fibrosis. The work is scheduled [...]
«« Read More
August 17th, 2010 by admin
( Genetics Society of America ) A new discovery about selective serotonin reuptake inhibitors suggests that these drugs, used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. Researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs. Such secondary pathways could help explain why [...]
«« Read More
August 17th, 2010 by admin
NEW YORK (GenomeWeb News) Interleukin Genetics has moved its stock from the New York Stock Exchange Amex to the Pink Quotes OTCQB, a new quotation service run by Pink OTC Markets, as of today.
«« Read More
August 17th, 2010 by admin
NEW YORK (GenomeWeb News) Interleukin Genetics has moved its stock from the New York Stock Exchange Amex to the Pink Quotes OTCQB, a new quotation service run by Pink OTC Markets, as of today.
«« Read More
August 17th, 2010 by admin
Interleukin Genetics, Inc. today announced that trading of shares of the Company’s common stock will be transferred from the NYSE Amex to the OTCQB⢠Marketplace effective today, August 16, 2010.
«« Read More
August 17th, 2010 by admin
Interleukin Genetics, Inc. today announced that trading of shares of the Company’s common stock will be transferred from the NYSE Amex to the OTCQB Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics’ symbol will now be ILIU.
«« Read More
August 16th, 2010 by admin
( NIH/National Human Genome Research Institute ) Using a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardation. Instead of sequencing the entire human genome, the new approach sequences just the exome, [...]
«« Read More
August 14th, 2010 by admin
Interleukin Genetics, Inc. (NYSE Amex: ILI) announced that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal disease progression to tooth loss using a new version of Interleukin Genetics’ PST genetic test. PST is the Company’s genetic test brand that identifies [...]
«« Read More
August 12th, 2010 by admin
Seattle Genetics, Inc. announced today that it has expanded its antibody-drug conjugate (ADC) collaboration agreement with Genentech, Inc., a member of the Roche Group. Under the expanded agreement, Genentech will pay an upfront fee of $12 million for rights to utilize Seattle Genetics’ ADC technology with additional antigens to be named by Genentech.
«« Read More
August 12th, 2010 by admin
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal disease progression to tooth loss using a new version of Interleukin Genetics’ PST genetic test.
«« Read More
August 12th, 2010 by admin
FROM a microscope and a small refrigerator to the countrys most comprehensive research laboratory on genetics. For this feat, the Institute of Human Genetics (IHG) received the 2010 Outstanding Health Research Award from the Philippine Council on Health Research and Development (PCHRD).
«« Read More